Complex Litigation Blog - Recent Legal News

View updates for:
Published: April 20th, 2015
An insurance industry trade group is pushing the U.S. Congress to take another look at medical device regulation, in the wake of mounting concerns over the use of power morcellators in uterine surgeries. According to a letter sent by America’s Health Insurance Plans (AHIP) to U.S. Senator Robe...Read More
Published: April 16th, 2015
Parties involved in hundreds of Xarelto lawsuits pending in the federal multidistrict litigation underway in the U.S. District Court, Eastern District of Louisiana, will soon have an opportunity to apprise the Court of medical and scientific matters likely to be relevant to plaintiffs’ claims. Acc...Read More
Published: April 14th, 2015
The U.S. Food & Drug Administration (FDA) is considering a proposed rule change that would allow generic drug makers to update their products’ labels whenever new health risks are discovered. According to a report published last month by The New York Times, generic manufacturers are currently ...Read More
Published: April 8th, 2015
Health insurers are taking another look at power morcellators, surgical tools that were once a popular option for women undergoing hysterectomies and myomectomies to remove uterine fibroids. According to a recent report from The Wall Street Journal, a growing number of health insurance companies are...Read More
Published: April 6th, 2015
GlaxoSmithKline has been named in another Zofran lawsuit over the drug’s alleged connection to birth defects. This latest case, which is now pending in U.S. District Court, Northern District of Alabama, was filed on behalf of a boy who was born with a chromosomal abnormality after his mother used ...Read More
Published: April 1st, 2015
As testosterone lawsuits involving AndroGel and similar drugs continue to make their way through U.S. courts, a newly-published editorial suggests that sales of low T treatments may have been fueled by “disease mongering” on the part of pharmaceutical companies. What is Disease Mongering? Acco...Read More
Published: March 30th, 2015
A dozen plaintiffs have filed a Xarelto lawsuit in California alleging the blood thinning medication was responsible for serious complications they experienced. According to the complaint, which is currently pending in U.S. District Court, Central District of California, all of the plaintiffs named ...Read More
Published: March 25th, 2015
A new analysis has found that many doctors are ignoring current treatment guidelines when they prescribe testosterone treatments like AndroGel to their male patients. The study, which appeared this month in Public Health Reports, echoes concerns recently raised by U.S. health regulators, as well as ...Read More
Published: March 23rd, 2015
A Pennsylvania juryconvened to weigh evidence in the trial of an important Risperdal lawsuit ruled on Friday that the antipsychotic medication did not cause the plaintiff’s excessive breast growth. However, the panel did agree with the lawsuit’s assertion that Johnson & Johnson and its Janss...Read More
Published: March 20th, 2015
Grenades were thrown by both sides at the second bellwether trial for a Risperdal a lawsuit, which follows a similar case that concluded in February with a $2.5 million damage award to the plaintiff. According to a report on March 19th, 2015, closing arguments in the proceeding’s second gynecom...Read More